Celldex Therapeutics Inc.

NASDAQ: CLDX · Real-Time Price · USD
20.75
-0.42 (-1.98%)
At close: Jun 27, 2025, 11:12 AM
-1.98%
Bid 20.73
Market Cap 1.38B
Revenue (ttm) 7.56M
Net Income (ttm) -178.85M
EPS (ttm) -2.7
PE Ratio (ttm) -7.68
Forward PE -5.35
Analyst Buy
Ask 20.79
Volume 309,217
Avg. Volume (20D) 952,706
Open 21.09
Previous Close 21.17
Day's Range 20.73 - 21.44
52-Week Range 14.40 - 47.00
Beta 1.14

About CLDX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLDX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CLDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Celldex Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
-12.06%
Celldex Therapeutics shares are trading lower. The... Unlock content with Pro Subscription
11 months ago
-8.45%
Celldex Therapeutics shares are trading lower. The company announced topline results from its Phase 2 clinical trial of barzolvolimab.